Merck has acquired all ownership rights to the ProcessPad platform from Simplyfeye Softwares. The agreement includes the transfer of all copyrights and relevant intellectual property related to this software platform.
ProcessPad technology helps efficiently capture all development, scale-up and commercial data on one single platform, while easily managing specifications history and simplifying the tech transfer process
The ProcessPad platform is a data management and analytics solution developed specifically for the pharmaceutical and biopharmaceutical industry. The platform performs the following tasks:
- Aggregates data from a variety of external data sources for various batches, parameters and unit operations, capturing all development, scale-up, commercial and process data on a single platform
- Analyses quantitative and qualitative batch manufacturing data using various process analysis tools, which also aid in troubleshooting
- Visualises the data by generating a variety of report, charts and tables for annual product reviews, root cause investigations and corrective and preventive action (CAPA) implementation, etc.
- Manages data through easy browser-based access to all process data from a variety of diverse stakeholders
The acquisition of the platform is another building block for Merck's BioContinuum Platform, a confluent offering of intensified, advanced processing and digital technologies and services that allow a customer to go beyond continuous processing. The BioContinuum Platform will deliver contiguous manufacturing for Biopharma 4.0, the industry-specific global vision and initiative based on Industry 4.0.
